During total follow up, endometrial adenocarcinoma was reported in 53 women randomized to Tamifine tamoxifen citrate 30 cases of FIGO Stage IA, 20 were Stage IB, 1 was Stage IC, and 2 were Stage IIIC, and 17 women randomized to placebo 9 cases were FIGO Stage IA, 6 were Stage IB, 1 was Stage IIIC, and 1 was Stage IVB incidence per 1, 000 women years of 2 <a href=https://nolvadex.buzz>hair loss with tamoxifen</a>